undamentalytics Newsletter

Outset Medical, Inc. cash flow statement

In fiscal 2025, Outset Medical, Inc.'s operations generated −$46.3m of cash; it spent $798,000 on capital projects, leaving free cash flow of −$47.1m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Outset Medical, Inc.: cash flow statement, annual
Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−46−70−99−130−146−131−116−46−38
Depreciation and amortisation113556643
Stock-based pay1121172739291615
Capital spending239383111
Free cash flow−48−74−108−133−154−135−117−47−39
Free cash flow after stock pay−49−74−130−151−181−173−147−63−54
Shares issued——25514900———

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ANIK vs OMOM vs OWLTOM vs SMTIBBNX vs OM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Outset Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Outset Medical, Inc.